pravastatin / Generic mfg.  >>  Phase 4
Welcome,         Profile    Billing    Logout  

11 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pravastatin / Generic mfg.
2004-003235-31: Effect of pravastatin or fluvastatin and add-on valsartan on inflammatory markers and peripheral endothelial function in patients with acute coronary syndrome

Ongoing
4
80
Europe
Lescol, Diovan, PRAVASTATIN "RATIOPHARM", Tablet, Lescol, Diovan, PRAVASTATIN "RATIOPHARM"
Div. of Cardiology, Innsbruck Medical University
Acute coronary syndrome; patients with NSTEMI
 
 
2010-023912-14: Evaluación de la eficacia de una herramienta de ayuda para la toma de decisiones (ELECCIÓN DE ESTATINAS) para personas con diabetes tipo 2Evaluation of the efficacy of a decision aid (STATIN CHOICE) for patients with type 2 diabetes mellitus

Ongoing
4
325
Europe
SIMVASTATINA, PRAVASTATINA,
Fundación Canaria de Investigación y Salud
Diabetes mellitus tipo 2
 
 
2011-001055-36: Randomized controlled clinical trial phase IV to validate a cost-effective tool to optimize statin treatment of diabetic dyslipidemia in primary care

Ongoing
4
28
Europe
Simvastatina, Atorvastatina, Rosuvastatina, Ezetimiba, Fluvastatina sodica, Pravastatina, Simvastatina, Atorvastatina, Rosuvastatina, Ezetimiba, Fluvastatina sodica, Pravastatina, Simvastatina, Atorvastatina, Rosuvastatina, Ezetimiba, Fluvastatina sodica, Pravastatina
Eduardo García Díaz, Eduardo García Díaz
Diabetes and cardiovascular events Diabetes y eventos carrdiovasculares
 
 
2009-011291-29: RACE 3 study: Intensive vs. usual rhythm control for atrial fibrillation.

Ongoing
4
250
Europe
eplerenone, Spironolactone, atorvastatin, Fluvastatin, Pravastatin, rosuvastatin, Simvastatin, eplerenone, spironolactone, atorvastatin, Fluvastatin, Pravastatin, rosuvastatin, Simvastatin, eplerenone, spironolactone, atorvastatin, Fluvastatin, Pravastatin, rosuvastatin, Simvastatin
Interuniversity Cardiology Institute of the Netherlands (ICIN), Interuniversity Cardiology Institute Netherlands, The Interuniversity Cardiology Institute of the Netherlands (ICIN), Netherlands Heart Foundation (NHS B 2008 035), Working group on Cardiovascular Research, the Netherlands, Sanofi Aventis, Boehringer Ingelheim, Medtronic, Biotronik, St Jude Medical, Boston Scientific, AstraZenenca, Interuniversity Cardiology Institute Netherlands, Working group on Cardiovascular Research, Astra Zeneca, Bayer
atrial fibrillation
 
 
NCT01816997: The Statins on Glucose Homeostasis in Subjects With Impaired Fasting Glucose

Recruiting
4
160
RoW
Pravastatin, Pravastatin (Mevalotin), Rosuvastatin, Crestor, Control, placebo
Taipei Veterans General Hospital, Taiwan
Diabetes
12/17
12/22
NCT04719481: Pravastatin Reduces Acute Phase Response of Zoledronic Acid

Not yet recruiting
4
110
NA
Pravastatin Sodium 80 MG, Meibailezhen, Placebo, Meibailezhen placebo
Peking University Third Hospital
Postmenopausal Osteoporosis
11/21
04/22
ChiCTR2100046704: Effects of Xuezhikang vs Pravastatin on triglyceride level in patients with Type 2 Diabetes Mellitus and Dyslipidemia: a multicenter, prospective, randomized controlled study

Recruiting
4
114
 
Xuezhikang capsule ;Pravastatin sodium tablets
The Second Xiangya Hospital of Central South University; The Second Xiangya Hospital of Central South University, Astrazeneca Investment (China) Co., Ltd.
Type 2 Diabetes Mellitus with Dyslipidemia
 
 
SCI-CT-0001, NCT06357104: Detoxification From the Lipid Tract

Completed
4
1
RoW
electroencephalogram biofeedback, EB, electrical brain stimulation, EBS, ultra-low frequency transcranial magnetic stimulation, ULF-TMS, Sertraline Hydrochloride, SSRI, Clonazepam, Alprazolam, Metoprolol, beta blocker, Olanzapine, Pravastatin Sodium 20 MG, Sacubitril Valsartan Sodium Hydrate, ARNI
Pachankis, Yang I., M.D., First Affiliated Hospital of Chongqing Medical University
COVID-19 Vaccine Adverse Reaction
03/24
03/24
PREVESTATGx, NCT06262685: Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins

Not yet recruiting
4
216
Europe
Preemptive pharmacogenetic atorvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic simvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic pitavastatin dose based on CPIC guidelines, Preemptive pharmacogenetic rosuvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic pravastatin dose based on CPIC guidelines, Preemptive pharmacogenetic lovastatin dose based on CPIC guidelines, Preemptive pharmacogenetic fluvastatin dose based on CPIC guidelines, Standard of Care (SoC) dosing of atorvastatin, Standard of Care (SoC) dosing of simvastatin, Standard of Care (SoC) dosing of pitavastatin, Standard of Care (SoC) dosing of rosuvastatin, Standard of Care (SoC) dosing of prasavastatin, Standard of Care (SoC) dosing of lovastatin, Standard of Care (SoC) dosing of fluvastatin
Instituto de Investigación Hospital Universitario La Paz, Instituto de Salud Carlos III
Cardiovascular Diseases, Dyslipidemias, Statin Adverse Reaction, Pharmacogenic Myopathy
02/25
03/25
NCT03273413: Statin Therapy in Patients With Early Stage ADPKD

Active, not recruiting
4
150
US
Pravastatin, Placebo
University of Colorado, Denver
ADPKD, Autosomal Dominant Polycystic Kidney
03/24
04/24
ChiCTR2000034035: Five-year prognosis of postmenopausal patients with hormone receptor-positive early breast cancer treated with different stains and aromatase inhibitors: a prospective, randomized controlled trial

Not yet recruiting
4
374
 
Simvastatin ;Pravastatin
The First Hospital of China Medical University; The First Hospital of China Medical University, self-raised
Breast Cancer
 
 

Download Options